Elucidating the role of T-cell exhaustion-related genes in colorectal cancer: a single-cell bioinformatics perspective.

Bioinformatics Colorectal cancer Prognostic risk model Single-cell analysis Tumor immune microenvironment

Journal

Functional & integrative genomics
ISSN: 1438-7948
Titre abrégé: Funct Integr Genomics
Pays: Germany
ID NLM: 100939343

Informations de publication

Date de publication:
02 Aug 2023
Historique:
received: 21 06 2023
accepted: 26 07 2023
revised: 23 07 2023
medline: 3 8 2023
pubmed: 2 8 2023
entrez: 1 8 2023
Statut: epublish

Résumé

Colorectal cancer (CRC) remains a significant global health issue. In this study, the role of T-cell exhaustion-related genes (TEXs) in CRC was investigated using single-cell and bulk RNA-seq analysis. This research involved extensive data analysis using multiple databases, including the TCGA-COAD cohort, GSE14333, and GSE39582. Through single-cell analysis, distinct cell populations within CRC samples were identified and classified T-cells into four subgroups: regulatory T-cells (Tregs), conventional CD4+ T-cells (CD4+ T conv), CD8+ T, and CD8+ T exhausted cells. Intercellular communication networks and signaling pathways associated with TEXs using computational tools such as CellChat and PROGENy. Additionally, TEX-related alterations in tumor gene pathways were analyzed through Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses. Prognostic models were developed, and their correlation with immune infiltration was assessed. The study revealed the presence of distinct cell populations within CRC, with TEXs playing a crucial role in the tumor microenvironment. CD8+ T exhausted cells exhibited expression of specific markers, indicating their involvement in tumor immune evasion. CellChat and PROGENy analyses revealed intricate communication networks and signaling pathways associated with TEXs, including RNA splicing and viral carcinogenesis. Furthermore, the prognostic risk model developed on the basis of TEXs demonstrated its efficacy in stratifying CRC patients. This risk model exhibited strong correlations with immune infiltration by various effector immune cells, highlighting the influence of TEXs on the tumor immune response. The complex interactions and signaling pathways underlying TEX-associated immune dysregulation in CRC were revealed by employing advanced analytical approaches. The development of a prognostic risk model based on TEXs offers a promising tool for prognostic stratification in patients with CRC. Furthermore, the correlations observed between TEXs and immune infiltration provide valuable insights into the potential of TEXs as therapeutic targets and highlight the need for further investigation into TEX-mediated immune evasion mechanisms. This study thus provides valuable insights into the role of TEXs in CRC.

Identifiants

pubmed: 37528306
doi: 10.1007/s10142-023-01188-9
pii: 10.1007/s10142-023-01188-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

259

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Arneth B (2019) Tumor microenvironment. Medicina (Kaunas) 56(1):15
doi: 10.3390/medicina56010015 pubmed: 31906017
Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM et al (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium Nat Genet 25(1):25–29
pubmed: 10802651
Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F et al (2016) Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol 17(1):218
doi: 10.1186/s13059-016-1070-5 pubmed: 27765066 pmcid: 5073889
Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK et al (2018) NCCN guidelines insights: colon cancer, Version 2.2018. J Natl Compr Canc Netw 16(4):359–369
doi: 10.6004/jnccn.2018.0021 pubmed: 29632055 pmcid: 10184502
Brenner H, Kloor M, Pox CP (2014) Colorectal cancer. Lancet 383(9927):1490–1502
doi: 10.1016/S0140-6736(13)61649-9 pubmed: 24225001
Cheng L, Xiong W, Li S, Wang G, Zhou J, Li H (2023) CRISPR-Cas9 screening identified lethal genes enriched in necroptosis pathway and of prognosis significance in osteosarcoma. J Gene Med:e3563
Collado M, Blasco MA, Serrano M (2007) Cellular senescence in cancer and aging. Cell 130(2):223–233
doi: 10.1016/j.cell.2007.07.003 pubmed: 17662938
Darvin P, Toor SM, Sasidharan Nair V, Elkord E (2018) Immune checkpoint inhibitors: recent progress and potential biomarkers. Exp Mol Med 50(12):1–11
doi: 10.1038/s12276-018-0191-1 pubmed: 30546008
Dolina JS, Van Braeckel-Budimir N, Thomas GD, Salek-Ardakani S (2021) CD8(+) T cell exhaustion in cancer. Front Immunol 12:715234
doi: 10.3389/fimmu.2021.715234 pubmed: 34354714 pmcid: 8330547
Huang H, Ke C, Zhang D, Wu J, Zhang P (2023) Molecular mechanism study and tumor heterogeneity of Chinese angelica and Fructus aurantii in the treatment of colorectal cancer through computational and molecular dynamics. Funct Integr Genomics 23(2):106
doi: 10.1007/s10142-023-01042-y pubmed: 36977932
Jhunjhunwala S, Hammer C, Delamarre L (2021) Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion. Nat Rev Cancer 21(5):298–312
doi: 10.1038/s41568-021-00339-z pubmed: 33750922
Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH et al (2021) Inference and analysis of cell-cell communication using CellChat. Nat Commun 12(1):1088
doi: 10.1038/s41467-021-21246-9 pubmed: 33597522 pmcid: 7889871
Kanehisa M, Goto S (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28(1):27–30
doi: 10.1093/nar/28.1.27 pubmed: 10592173 pmcid: 102409
Kobak D, Berens P (2019) The art of using t-SNE for single-cell transcriptomics. Nat Commun 10(1):5416
doi: 10.1038/s41467-019-13056-x pubmed: 31780648 pmcid: 6882829
Li H, Yu L, Zhang X, Shang J, Duan X (2022) Exploring the molecular mechanisms and shared gene signatures between rheumatoid arthritis and diffuse large B cell lymphoma. Front Immunol 13:1036239
doi: 10.3389/fimmu.2022.1036239 pubmed: 36389761 pmcid: 9659608
Li H, Zhang X, Shang J, Feng X, Yu L, Fan J et al (2023a) Identification of NETs-related biomarkers and molecular clusters in systemic lupus erythematosus. Front Immunol 14:1150828
doi: 10.3389/fimmu.2023.1150828 pubmed: 37143669 pmcid: 10151561
Li H, Zhou J, Zhou L, Zhang X, Shang J, Feng X et al (2023b) Identification of the shared gene signatures and molecular pathways in systemic lupus erythematosus and diffuse large B-cell lymphoma. J Gene Med:e3558
Liu Y, Liu J, Tian Z, Zhang Z, Liu T, Chen C et al (2021) Highly expressed IFITM10 is associated with early diagnosis and T stage of gastric cancer. Transl Cancer Res 10(1):382–392
doi: 10.21037/TCR-20-2333 pubmed: 35116268 pmcid: 8798903
Luo G, Sun Y, Feng R, Zhao Q, Wen T (2018) ARL3 subcellular localization and its suspected role in autophagy. Biochimie 154:187–193
doi: 10.1016/j.biochi.2018.09.007 pubmed: 30227171
Morad G, Helmink BA, Sharma P, Wargo JA (2021) Hallmarks of response, resistance, and toxicity to immune checkpoint blockade. Cell 184(21):5309–5337
doi: 10.1016/j.cell.2021.09.020 pubmed: 34624224 pmcid: 8767569
Powell L, Samarakoon YH, Ismail S, Sayer JA (2021) ARL3, a small GTPase with a functionally conserved role in primary cilia and immune synapses. Small GTPases 12(3):167–176
doi: 10.1080/21541248.2019.1703466 pubmed: 31826708
Rayess H, Wang MB, Srivatsan ES (2012) Cellular senescence and tumor suppressor gene p16. Int J Cancer 130(8):1715–1725
doi: 10.1002/ijc.27316 pubmed: 22025288
Rigatti SJ (2017) Random forest. J Insur Med 47(1):31–39
doi: 10.17849/insm-47-01-31-39.1 pubmed: 28836909
Schubert M, Klinger B, Klünemann M, Sieber A, Uhlitz F, Sauer S et al (2018) Perturbation-response genes reveal signaling footprints in cancer gene expression. Nat Commun 9(1):20
doi: 10.1038/s41467-017-02391-6 pubmed: 29295995 pmcid: 5750219
Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S et al (2016) The GeneCards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics 54(1):1–30
doi: 10.1002/cpbi.5
Wherry EJ (2011) T cell exhaustion. Nat Immunol 12(6):492–499
doi: 10.1038/ni.2035 pubmed: 21739672
Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z et al (2021) clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation (Camb) 2(3):100141
pubmed: 34557778
Xiao Y, Yu D (2021) Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther 221:107753
doi: 10.1016/j.pharmthera.2020.107753 pubmed: 33259885
Xing X, Cai W, Shi H, Wang Y, Li M, Jiao J et al (2013) The prognostic value of CDKN2A hypermethylation in colorectal cancer: a meta-analysis. Br J Cancer 108(12):2542–2548
doi: 10.1038/bjc.2013.251 pubmed: 23703248 pmcid: 3694241
Zhang L, Liu C, Zhang X, Wang C, Liu D (2023) Breast cancer prognosis and immunological characteristics are predicted using the m6A/m5C/m1A/m7G-related long noncoding RNA signature. Funct Integr Genomics 23(2):117
doi: 10.1007/s10142-023-01026-y pubmed: 37014493

Auteurs

Wei Tu (W)

Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Nanchang, Nanchang, 330000, China.

Yan Tu (Y)

Emergency and Trauma Center, The First Hospital of Nanchang, Nanchang, 330000, China.

Chunhong Tan (C)

Department of Endocrinology and Metabolism, The First Hospital of Nanchang, Nanchang, 330000, China.

Honghong Zhong (H)

Department of General Surgery, The First Hospital of Nanchang, Nanchang, 330000, China.

Sheng Xu (S)

Department of Material Supply, The First Hospital of Nanchang, Nanchang, 330000, China.

Jun Wang (J)

Department of General Surgery, The First Hospital of Nanchang, Nanchang, 330000, China. 484688865@qq.com.

Lv Huang (L)

Department of Rehabilitation Medicine, Nanchang Hongdu Hospital of TCM, Nanchang, 330000, China.

Ling Cheng (L)

Department of Rehabilitation Medicine, Nanchang Hongdu Hospital of TCM, Nanchang, 330000, China.

Haoguang Li (H)

School of Medicine, Nanchang University, Nanchang, 330000, China. 363007220014@email.ncu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH